HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparative trial of oltipraz versus praziquantel in the treatment of urinary schistosomiasis in the Gabon.

Abstract
The efficacy of oltipraz as a schistosomicidal drug was investigated in Gabonese children suffering from urinary schistosomiasis in the dosages of 1 X 25 mg/kg body weight, 1 X 35 mg/kg body weight, and 2 X 20 mg/kg body weight and compared to praziquantel, 2 X 30 mg/kg body weight. The study was undertaken in 165 patients, and follow-up investigations were carried out 6 weeks and 12 weeks after treatment. Oltipraz showed less efficacy compared to praziquantel when dosages of 1 X 25 and 1 X 35 mg/kg body weight were given. However, oltipraz 2 X 20 mg/kg body weight was equivalent to praziquantel 2 X 30 mg/kg body weight. Parasitological cure was obtained in 79% of patients treated by oltipraz and 81% of patients treated by praziquantel. Side effects were insignificant in both treatment groups. Thus, the same parasitological cure could be achieved by oltipraz as well as by praziquantel, but with a lower dosage of oltipraz.
AuthorsG D Burchard, P Kern, R Baltes, M Dietrich
JournalTropenmedizin und Parasitologie (Tropenmed Parasitol) Vol. 35 Issue 2 Pg. 91-4 (Jun 1984) ISSN: 0303-4208 [Print] Germany
PMID6464191 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Isoquinolines
  • Pyrazines
  • Schistosomicides
  • Thiones
  • Thiophenes
  • Praziquantel
  • oltipraz
Topics
  • Adolescent
  • Child
  • Female
  • Gabon
  • Humans
  • Isoquinolines (therapeutic use)
  • Male
  • Parasite Egg Count
  • Praziquantel (administration & dosage, therapeutic use)
  • Pyrazines (administration & dosage, therapeutic use)
  • Schistosoma
  • Schistosoma haematobium
  • Schistosomiasis (drug therapy)
  • Schistosomicides (administration & dosage, therapeutic use)
  • Species Specificity
  • Thiones
  • Thiophenes
  • Urine (parasitology)
  • Urologic Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: